M&A Activity
Cannabis Telehealth Platform Veri Medtech Sets Terms for $15m Nasdaq IPO
Veriheal parent Veri Medtech Holdings has priced a $15m IPO at $4 per share, with plans to uplist from the OTC market to Nasdaq.
Rob Dale
May 8, 2026
